Falchook GS - Search Results

1

Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial.

Falchook GS, Lewis KD, Infante JR, Gordon MS, Vogelzang NJ, DeMarini DJ, Sun P, Moy C, Szabo SA, Roadcap LT, Peddareddigari VG, Lebowitz PF, Le NT, Burris HA 3rd, Messersmith WA, O'Dwyer PJ, Kim KB, Flaherty K, Bendell JC, Gonzalez R, Kurzrock R, Fecher LA. Falchook GS, et al. Lancet Oncol. 2012 Aug;13(8):782-9. doi: 10.1016/S1470-2045(12)70269-3. Epub 2012 Jul 16. Lancet Oncol. 2012. PMID: 22805292 Free PMC article. Clinical Trial.

2

Clinicopathologic features and treatment strategies for patients with pancreatic adenocarcinoma and ovarian metastases.

Falchook GS, Wolff RA, Varadhachary GR. Falchook GS, et al. Gynecol Oncol. 2008 Mar;108(3):515-9. doi: 10.1016/j.ygyno.2007.11.012. Gynecol Oncol. 2008. PMID: 18164378

3

Phase I clinical trials in 85 patients with gynecologic cancer: the M. D. Anderson Cancer Center experience.

Moroney J, Wheler J, Hong D, Naing A, Falchook G, Bodurka D, Coleman R, Lu K, Xiao L, Kurzrock R. Moroney J, et al. Gynecol Oncol. 2010 Jun;117(3):467-72. doi: 10.1016/j.ygyno.2010.02.008. Epub 2010 Mar 26. Gynecol Oncol. 2010. PMID: 20347123 Free PMC article. Clinical Trial.

4

Patients with advanced head and neck cancers have similar progression-free survival on phase I trials and their last food and drug administration-approved treatment.

Garrido-Laguna I, Janku F, Falchook GS, Fu S, Hong DS, Naing A, Aaron J, Wang X, Kies M, Kurzrock R. Garrido-Laguna I, et al. Among authors: falchook gs. Clin Cancer Res. 2010 Aug 1;16(15):4031-7. doi: 10.1158/1078-0432.CCR-10-0672. Epub 2010 Jun 4. Clin Cancer Res. 2010. PMID: 20525754

5

PIK3CA mutations in patients with advanced cancers treated with PI3K/AKT/mTOR axis inhibitors.

Janku F, Tsimberidou AM, Garrido-Laguna I, Wang X, Luthra R, Hong DS, Naing A, Falchook GS, Moroney JW, Piha-Paul SA, Wheler JJ, Moulder SL, Fu S, Kurzrock R. Janku F, et al. Among authors: falchook gs. Mol Cancer Ther. 2011 Mar;10(3):558-65. doi: 10.1158/1535-7163.MCT-10-0994. Epub 2011 Jan 7. Mol Cancer Ther. 2011. PMID: 21216929 Free PMC article.

6

Prevalence of complementary medicine use in a phase 1 clinical trials program: the MD Anderson Cancer Center Experience.

Naing A, Stephen SK, Frenkel M, Chandhasin C, Hong DS, Lei X, Falchook G, Wheler JJ, Fu S, Kurzrock R. Naing A, et al. Cancer. 2011 Nov 15;117(22):5142-50. doi: 10.1002/cncr.26164. Epub 2011 Apr 28. Cancer. 2011. PMID: 21538342 Free article.

7

Phase I trial of hepatic arterial infusion of nanoparticle albumin-bound paclitaxel: toxicity, pharmacokinetics, and activity.

Fu S, Naing A, Moulder SL, Culotta KS, Madoff DC, Ng CS, Madden TL, Falchook GS, Hong DS, Kurzrock R. Fu S, et al. Among authors: falchook gs. Mol Cancer Ther. 2011 Jul;10(7):1300-7. doi: 10.1158/1535-7163.MCT-11-0259. Epub 2011 May 13. Mol Cancer Ther. 2011. PMID: 21571911 Clinical Trial.

8

Validation of the Royal Marsden Hospital prognostic score in patients treated in the Phase I Clinical Trials Program at the MD Anderson Cancer Center.

Garrido-Laguna I, Janku F, Vaklavas C, Falchook GS, Fu S, Hong DS, Naing A, Tsimberidou AM, Wen S, Kurzrock R. Garrido-Laguna I, et al. Among authors: falchook gs. Cancer. 2012 Mar 1;118(5):1422-8. doi: 10.1002/cncr.26413. Epub 2011 Aug 5. Cancer. 2012. PMID: 21823111 Free article.

9

PIK3CA mutations frequently coexist with RAS and BRAF mutations in patients with advanced cancers.

Janku F, Lee JJ, Tsimberidou AM, Hong DS, Naing A, Falchook GS, Fu S, Luthra R, Garrido-Laguna I, Kurzrock R. Janku F, et al. Among authors: falchook gs. PLoS One. 2011;6(7):e22769. doi: 10.1371/journal.pone.0022769. Epub 2011 Jul 29. PLoS One. 2011. PMID: 21829508 Free PMC article.

10

Outcome analyses after the first admission to an intensive care unit in patients with advanced cancer referred to a phase I clinical trials program.

Fu S, Hong DS, Naing A, Wheler J, Falchook G, Wen S, Howard A, Barber D, Nates J, Price K, Kurzrock R. Fu S, et al. J Clin Oncol. 2011 Sep 10;29(26):3547-52. doi: 10.1200/JCO.2010.33.3823. Epub 2011 Aug 15. J Clin Oncol. 2011. PMID: 21844494

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

193 results

Search Page

Filters